Alcon AG (ALC)

Currency in USD
76.55
+1.18(+1.57%)
Closed·
76.75+0.20(+0.26%)
·
ALC Scorecard
Full Analysis
Has raised its dividend for 5 consecutive years
ALC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
75.3277.00
52 wk Range
73.2299.20
Key Statistics
Prev. Close
75.37
Open
75.47
Day's Range
75.32-77
52 wk Range
73.22-99.2
Volume
1.79M
Average Volume (3m)
2.01M
1-Year Change
-20.19%
Book Value / Share
44.61
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Alcon AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Alcon AG Company Profile

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Alcon AG SWOT Analysis


Eye Care Evolution
Alcon navigates a competitive landscape while leveraging its robust product pipeline, balancing challenges and opportunities in the global eye care market.
Financial Resilience
Despite mixed Q2 2024 results, Alcon demonstrates strong operational efficiency with margins exceeding expectations. EPS projections indicate steady growth.
Competitive Dynamics
Explore how Alcon faces pressure from established players and innovative newcomers, potentially impacting its dominant position in the U.S. PC-IOL market.
Growth on the Horizon
Discover Alcon's multi-year upgrade cycle, including new surgical systems, glaucoma treatments, and expansion in China, with price targets ranging from $95 to $110.
Read full SWOT analysis

Alcon AG Earnings Call Summary for Q2/2025

  • Q2 EPS of $0.76 beat expectations, but revenue of $2.58B missed forecast; stock dropped 9.17% in premarket trading
  • Sales grew 3% YoY, driven by 5% increase in Vision Care and 7% rise in contact lens sales; surgical franchise saw 1% growth
  • Core operating margin declined 100 basis points to 19.1%; free cash flow reached $681M for H1 2025
  • Company maintained full-year EPS guidance of $3.05-$3.15, expecting accelerated sales growth in H2, particularly Q4
  • CEO expressed optimism about long-term growth, citing aging population and strategic product launches as key drivers
Last Updated: 20/08/2025, 14:20
Read Full Transcript

Compare ALC to Peers and Sector

Metrics to compare
ALC
Peers
Sector
Relationship
P/E Ratio
35.3x27.1x−0.7x
PEG Ratio
−12.970.520.00
Price/Book
1.7x2.6x2.6x
Price / LTM Sales
3.8x2.6x3.4x
Upside (Analyst Target)
32.7%16.4%35.7%
Fair Value Upside
Unlock7.3%4.1%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.16%
Dividend Yield
0.28%
Industry Median 1.28%
Annualised payout
0.22
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 20, 2025
EPS / Forecast
0.76 / 0.72
Revenue / Forecast
2.60B / 2.63B
EPS Revisions
Last 90 days

ALC Income Statement

People Also Watch

106.50
NOVN
+1.27%
579.80
ZURN
+0.87%
544.80
LONN
+0.85%
32.82
UBSG
+0.98%

FAQ

What Stock Exchange Does Alcon AG Trade On?

Alcon AG is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Alcon AG?

The stock symbol for Alcon AG is "ALC."

What Is the Alcon AG Market Cap?

As of today, Alcon AG market cap is 37.88B.

What Is Alcon AG's Earnings Per Share (TTM)?

The Alcon AG EPS (TTM) is 2.16.

When Is the Next Alcon AG Earnings Date?

Alcon AG will release its next earnings report on 11 Nov 2025.

From a Technical Analysis Perspective, Is ALC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Alcon AG Stock Split?

Alcon AG has split 0 times.

How Many Employees Does Alcon AG Have?

Alcon AG has 25000 employees.

What is the current trading status of Alcon AG (ALC)?

As of 09 Oct 2025, Alcon AG (ALC) is trading at a price of 76.55, with a previous close of 75.37. The stock has fluctuated within a day range of 75.32 to 77.00, while its 52-week range spans from 73.22 to 99.20.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.